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Background: Dyslipidemia is a common complication in patients with diabetes and is involved in being prone to
cardiovascular disease. The risk of coronary artery disease is known to be lower in light-to-moderate drinkers than
in abstainers. The aim of this study was to clarify whether and how alcohol drinking influences the lipid-related
indices, good predictors for cardiovascular disease, such as the ratio of LDL cholesterol to HDL cholesterol (LDL-C/
HDL-C ratio), the ratio of triglycerides to HDL cholesterol (TG/HDL-C ratio), and the lipid accumulation product
(LAP), in patients with diabetes.
Methods: The subjects were men with diabetes (n = 1477; mean age, 54.0 years) and they were divided into non-,
light (< 22 g ethanol/day), moderate (≥ 22 and < 44 g ethanol/day) and heavy (≥ 44 g ethanol/day) drinkers. The
relationships between alcohol intake and the lipid-related indices were investigated by the multivariate analyses
with adjustment for age, smoking, regular exercise and drug therapy for diabetes.
Results: The odds ratio (OR) vs. nondrinkers for high LDL-C/HDL-C ratio tended to be lower with an increase in
alcohol intake (OR with 95% confidence interval (CI): 0.80 [0.50-1.29] in light drinkers; 0.24 [0.15-0.38] in moderate
drinkers and 0.10 [0.05-0.19] in heavy drinkers). Alcohol intake showed an inverse association with a high TG/HDL-C
ratio (OR with 95% CI vs. nondrinkers for high TG/HDL-C ratio: 0.54 [0.36-0.80] in light drinkers; 0.73 [0.56-0.97] in
moderate drinkers and 0.72 [0.53-0.98] in heavy drinkers) and a J-shaped relationship with a high LAP (OR with
95% CI vs. nondrinkers for high LAP: 0.66 [0.43-1.02] in light drinkers; 0.82 [0.61-1.10] in moderate drinkers, and 1.29
[0.95-1.77] in heavy drinkers). Similar associations between alcohol intake and the lipid indices were obtained in a
covariance analysis.
Conclusions: In patients with diabetes, light-to-moderate alcohol consumption is inversely associated with lipid-
related indices, and this correlates with previous findings of cardiovascular risk reduction by modest drinking in
patients with diabetes.Introduction
The risk of cardiovascular disease is known to be lower in
light-to-moderate alcohol drinkers than in abstainers [1].
The effects of alcohol on lipid metabolism, especially the
HDL cholesterol-elevating effects, are thought to greatly
contribute to the cardioprotective action of alcohol [2].
On the other hand, excessive alcohol consumption has
been shown to cause hypertriglyceridemia [3,4], which is a
prevalent risk factor for cardiovascular disease [5-7]. With
regard to mechanisms underlying the effects of alcohol on* Correspondence: wakabaya@hyo-med.ac.jp
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distribution, and reproduction in any mediumlipid metabolism, alcohol consumption has been shown to
increase the activity of lipoprotein lipase and decrease the
activity of cholesteryl ester transfer protein, resulting in
elevation of HDL cholesterol [8]. The hypertriglyceridemia
induced by excessive alcohol drinking may be mainly due
to an increase in the synthesis of large VLDL particles in
the liver [4].
Diabetes mellitus is a major risk factor for cardiovas-
cular disease. An inverse association between moderate
drinking and the incidence of diabetes has been sug-
gested in recent systemic reviews [9,10], although it is
still under debate whether there is a causal relationship
between alcohol and diabetes. Patients with diabetes areBioMed Central Ltd. This is an Open Access article distributed under the terms
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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levels, low HDL cholesterol levels, and a preponder-
ance of small dense LDL particles, and a high preva-
lence of dyslipidemia contributes to the pathogenesis
of atherosclerotic macrovascular disease in patients
with diabetes [11,12].
Several lipid-related indices have been proposed by
previous studies to monitor patients for prediction of
cardiovascular disease. In addition to the ratio of LDL
cholesterol to HDL cholesterol (LDL-C/HDL-C ratio), a
classical atherogenic index [13], the ratio of triglycerides
to HDL cholesterol (TG/HDL-C ratio) has been shown
to be a good discriminator for cardiovascular risk [14,15]
and to reflect atherogenic small dense LDL particles
[16]. The TG/HDL-C ratio has also been demonstrated
to be associated with insulin resistance [17] and meta-
bolic syndrome [18]. Lipid accumulation product (LAP),
a continuous marker of lipid over-accumulation calcu-
lated by using the waist circumference and triglyceride
levels, has recently been proposed to be a good predictor
for cardiovascular disease [19] and diabetes [20]. Al-
though light-to-moderate drinking has been reported to
show inverse associations with these lipid-related indices
in a general population [21-23], it is unknown whether
and how alcohol drinking influences the lipid indices in
patients with diabetes. The purpose of this study was
therefore to clarify the relationships between alcohol in-
take and lipid indices, including LDL-C/HDL-C ratio,
TG/HDL-C ratio and LAP, in patients with diabetes.Methods
Subjects
A cross-sectional study was performed using a local
population-based database. The subjects in the original
database of the health checkup were male workers aged
from 35 to 70 years (n = 37693) who had received periodic
health examinations at their workplaces in Yamagata Pre-
fecture in Japan. Subjects with diabetes (n = 1477) were
extracted from the database according to the definition of
diabetes given below. Subjects with diabetes were defined
as those showing high hemoglobin A1C levels (≥ 6.5%),
according to the recent criteria for diagnosis of diabetes
by the American Diabetes Association [24], and/or having
a current history of drug therapy for diabetes. Those
receiving treatment for dyslipidemia were excluded from
the subjects. All of the subjects were of Japanese origin.
Subjects who were receiving treatment for any illness
were requested to state the names of the diseases in a
questionnaire at the health checkup. This study was ap-
proved by the Ethics Committee of Yamagata University
School of Medicine. The histories of alcohol consump-
tion, cigarette smoking and regular exercise were also
surveyed by questionnaires.Classification of drinker groups
The average alcohol consumption of each subject per
week was reported on questionnaires during health
examinations at each workplace. Since it is difficult to
know the correct average alcohol consumption of occa-
sional drinkers, only regular drinkers who drank almost
every day were used as drinkers for the analysis in this
study. The usual daily alcohol consumption was calcu-
lated in terms of the equivalent number of “go”, a trad-
itional Japanese unit of sake (rice wine). The amounts of
other alcoholic beverages, including beer, wine, whisky
and shochu (a traditional Japanese distilled spirit), were
converted and expressed as units of “go”. One go ap-
proximately corresponds to 180 ml of sake, 500 ml of
beer, 240 ml of wine, 60 ml of whisky and 80 ml of
shochu. The amount of alcohol consumed daily was
categorized as “null”, “less than 1 go per day”, “1 go or
more, but less than 2 go per day”, “2 go or more, but less
than 3 go per day” and “3 go or more per day”. One “go”
contains about 22 g of ethanol, and this amount was
used to separate moderate drinkers from light drinkers
since it is generally accepted that alcohol intake should
be reduced to less than 20 – 30 g per day from the view-
point of the prevention of hypertension [25,26]. The
average daily alcohol intake (grams of ethanol per day)
was then calculated. The subjects were divided into four
groups according to the ethanol consumption per day
(non-drinkers; light drinkers: < 22 g of ethanol per day;
moderate drinkers: ≥ 22 g and < 44 g of ethanol per day;
heavy drinkers: ≥ 44 g of ethanol per day).
Measurements
The height and body weight were measured with the
subjects wearing light clothes at the health checkup. The
waist circumference was measured at the navel level
according to the recommendation of the definition of
the Japanese Committee for the Diagnostic Criteria of
Metabolic Syndrome [27]. Fasted blood was sampled
from each subject in the morning, and the serum triglyc-
erides, HDL cholesterol and LDL cholesterol levels were
measured by enzymatic methods using commercial kits:
the pureauto S TG-N, cholestest N-HDL and cholestest
LDL (Sekisui Medical Co., Ltd, Tokyo, Japan), respect-
ively. The coefficients of variation for the reproducibility
of each measurement were ≤ 3% for triglycerides, ≤ 5%
for HDL cholesterol and ≤ 5% for LDL cholesterol. The
cut-off values for a high LDL-C/HDL-C ratio and high
TG/HDL-C ratio were defined as 3.5 and 3.75, respect-
ively. The LAP was determined by using the triglycerides
(TG) level and waist circumference (WC) as follows:
LAP = TG (mmol/L) × (WC (cm) – 65) [19]. The values
of LAP were arranged in ascending order, and the subjects
were then divided into three groups of approximately
equal sizes. Subjects in the highest tertile of LAP were
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cut-off value for LAP has not been confirmed.
Hemoglobin A1c was measured by the NGSP (National
Glycohemoglobin Standardization Program)-approved
technique using the latex cohesion method with a com-
mercial kit (Determiner HbA1c, Kyowa Medex, Tokyo,
Japan). The coefficient of variation for reproducibility of
the hemoglobin A1c measurement was ≤ 5%. Since the
standards of hemoglobin A1c used for measurement are
different in the NGSP method and JDS (the Japan
Diabetes Society) method, the hemoglobin A1c values
were calibrated by using a formula proposed by the JDS
[28]: hemoglobin A1c (NGSP) (%) = 1.02 × hemoglobin
A1c (JDS) (%) + 0.25%.
Statistical analysis
The statistical analyses were performed using a computer
software program (SPSS version 16.0 J for Windows,
Chicago IL, USA). The percentages of smokers, subjects
exercising regularly and subjects receiving drug therapy
for diabetes were compared between each pair of groups
using the chi-square test for independence. In the uni-
variate analysis, means of each variable were compared
among the groups by using an analysis of variance
(ANOVA) followed by Scheffé’s F-test as a post-hoc test.
In the multivariate analysis, the mean levels of each
variable were compared by using an analysis of covariance
(ANCOVA), followed by Student’s t-test after Bonferroni
correction. Since the triglycerides, TG/HDL-C ratio and
LAP levels did not show a normal distribution, these




Age (years) 52.4 ± 8.6 56.1 ± 6.4**
Body weight (kg) 72.9 ± 15.6 69.4 ± 10.9*
Waist circumference (cm) 89.0 ± 11.6 86.9 ± 8.2
Smokers (%) 48.5 48.5
Regular exercise (%) 9.9 13.8
Drug therapy for diabetes (%) 52.9 54.5
Hemoglobin A1c (%) 7.84 ± 1.72 7.68 ± 1.57
Triglycerides (mg/dl) 144 (93, 223) 120 (78, 175)**
HDL cholesterol (mg/dl) 47.1 ± 11.8 53.1 ± 13.5**
LDL cholesterol (mg/dl) 124.9 ± 31.5 122.3 ± 32.2
LDL-C/HDL-C ratio 2.81 ± 0.96 2.47 ± 0.93**
TG/HDL-C ratio 3.16 (1.87, 5.58) 2.33 (1.42, 3.79)**
LAP 38.2 (18.7, 65.5) 28.2 (18.5, 50.4)**
The numbers of subjects in each group, percentage of subjects with a smoking hab
means with the standard deviations for each variable and the medians with 25th an
significant differences from nondrinkers (*, p < 0.05; **, p < 0.01). A marginally signifparametrically by using the Kruskal-Wallis test, followed
by the Steel-Dwass test as a post-hoc test in the univariate
analysis (ANOVA), or were used after log-transformation
in the multivariate analysis (ANCOVA). In the logistic
regression analysis, the crude and adjusted odds ratios for
a high LDL-C/HDL-C ratio, high TG/HDL-C ratio, high
LAP or a combination of these high lipid indices were cal-
culated. Age, smoking, regular exercise and drug therapy
for diabetes were used as other explanatory variables or
covariables in the multivariate analyses. In the analyses of
variables other than waist circumference and LAP, body
weight was also added to the explanatory variables and
covariables. Probability (p) values less than 0.05 were de-
fined as significant.
Results
Characteristics of the subject groups
Table 1 shows the results of comparison of the alcohol
groups by a univariate analysis. Body weight and waist
circumference were significantly lower and smaller,
respectively, in light and moderate drinkers than in non-
drinkers. The percentage of smokers was significantly
higher in moderate and heavy drinkers than in non-
drinkers, while there was no significant difference in the
percentage of subjects doing regular exercise among the
alcohol groups. The triglyceride level was significantly
lower in light drinkers than in nondrinkers and was
higher with a marginal significance (p = 0.053) in heavy
drinkers than in nondrinkers. The HDL cholesterol level
was significantly higher in light, moderate and heavy
drinkers than in nondrinkers, while the LDL cholesterolderate drinkers and heavy drinkers in patients with
Moderate drinkers Heavy drinkers Overall
439 304 1477
55.2 ± 7.1** 54.1 ± 6.6* 54.0 ± 7.7
68.6 ± 11.0** 71.0 ± 11.9 70.8 ± 13.2




7.48 ± 1.41** 7.70 ± 1.44 7.69 ± 1.56
131 (81, 216) 164 (99, 256)# 142 (90, 223)
56.5 ± 14.7** 57.2 ± 14.7** 52.7 ± 14.3
115.7 ± 32.1** 111.1 ± 34.8** 119.0 ± 32.9
2.19 ± 0.82** 2.06 ± 0.82** 2.43 ± 0.94
2.36 (1.31, 4.47)** 2.96 (1.65, 5.46) 2.77 (1.56, 5.00)
32.6 (16.7, 58.5) 40.4 (22.0, 73.9)** 36.0 (18.5, 63.8)
it, a habit of regular exercise or who received drug therapy for diabetes, the
d 75th percentile values of each variable are shown. Symbols denote
icant difference from nondrinkers (#, p = 0.053).
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drinkers than in nondrinkers. The LDL-C/HDL-C ratio
was significantly lower in light, moderate and heavy
drinkers than in nondrinkers and tended to be lower
with an increase in alcohol intake. The TG/HDL-C ratio
was significantly lower in light and moderate drinkers
than in nondrinkers. The LAP was significantly lower in
light drinkers and significantly higher in heavy drinkers
when compared with that in nondrinkers.
Comparison of hemoglobin A1c among alcohol groups by
the multivariate analysis
The hemoglobin A1c levels (means with standard er-
rors) were 7.83 ± 0.06%, 7.78 ± 0.12%, 7.50 ± 0.07% and
7.64 ± 0.09% in nondrinkers, light drinkers, moderate
drinkers and heavy drinkers, respectively. Hemoglobin
























































Figure 1 Comparison of the variables determining the lipid indices am
diabetes. The mean levels of variables (A, waist circumference; B, log-trans
calculated after adjustment for age, smoking, regular exercise and drug the
calculate the means of the variables other than waist circumference. Symb
p < 0.01) and light drinkers (†, p < 0.05; ††, p < 0.01).in nondrinkers, and there was a tendency of an inverted
J-shaped relationship between the alcohol intake and
hemoglobin A1c level, although there were no significant
differences in hemoglobin A1c between light drinkers and
nondrinkers and between heavy drinkers and nondrinkers.
Comparison of the variables determining the lipid-related
indices among alcohol groups by the multivariate
analysis
Figure 1 shows the means of each variable determining
the lipid indices calculated with adjustment for age,
smoking, exercise and drug therapy for diabetes. Body
weight was also adjusted to calculate the means of the
variables other than waist circumference. Waist circum-
ference was significantly smaller in moderate drinkers
than in nondrinkers (Figure 1A). The log-transformed tri-
























































ong non-, light, moderate and heavy drinkers in patients with
formed triglycerides; C, HDL cholesterol; D, LDL cholesterol) were
rapy for diabetes. Body weight was also added to covariates to
ols denote significant differences from nondrinkers (*, p < 0.05; **,
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HDL cholesterol level was significantly higher in light,
moderate and heavy drinkers than in nondrinkers and
tended to be higher with an increase in alcohol intake
(Figure 1C). The LDL cholesterol level was significantly
lower in moderate and heavy drinkers than in nondrinkers
and light drinkers (Figure 1D).
Comparison of the lipid-related indices among alcohol
groups by the multivariate analysis
The mean levels of each lipid index calculated with ad-
justment for the aforementioned confounders are shown
in Figure 2. The LDL-C/HDL-C ratio was significantly
lower in light, moderate and heavy drinkers than in non-
drinkers and tended to be lower with an increase in
alcohol intake (Figure 2A). The log-transformed TG/
HDL-C ratio was significantly lower in light and moderate
drinkers than in nondrinkers (Figure 2B). Log-transformed
LAP was significantly higher in heavy drinkers than in
light drinkers. Log-transformed LAP tended to be lower in
light drinkers and higher in heavy drinkers compared with
that in nondrinkers, although the differences were not sig-
nificant (Figure 2C).
Odds ratios for high lipid indices in each drinker group
vs. the nondrinker group
Table 2 shows the odds ratios vs. nondrinkers for the
high lipid indices. Both the crude and adjusted odds
ratios for a high LDL-C/HDL-C ratio were significantly
lower in moderate and heavy drinkers compared with a
reference level of 1.00 and tended to be lower with an
increase in alcohol intake. Both the crude and adjusted
odds ratios for a high TG/HDL-C ratio were significantly
lower in the light, moderate and heavy drinker groups




















































Figure 2 Comparison of the lipid indices among non-, light, moderat
variables (A, LDL-C/HDL-C ratio; B, log-transformed TG/HDL-C ratio; C, log-t
regular exercise and drug therapy for diabetes. Body weight was also adde
Symbols denote significant differences from nondrinkers (**, p < 0.01) and lcrude odds ratio of heavy drinkers, which was marginally
significant (p = 0.077). The crude odds ratios for a high
LAP were significantly lower in light and moderate
drinkers compared with a reference level of 1.00, and the
corresponding adjusted odds ratio also tended to be lower
than the reference level. On the other hand, the crude and
adjusted odds ratios for a high LAP of heavy drinkers vs.
nondrinkers tended to be higher than the reference level,
although the differences were not significant.
Odds ratios for accumulation of high lipid indices in each
drinker group vs. the nondrinker group
As shown in Table 3, both the crude and adjusted odds
ratios of light and moderate drinkers vs. nondrinkers
for ≥ one high lipid index, ≥ two high lipid indices or
three high lipid indices were significantly lower than a
reference level of 1.00, except for a marginal significance
of the adjusted odds ratio of light drinkers vs. non-
drinkers for three high lipid indices (p = 0.091). The
crude and adjusted odds ratios of heavy drinkers vs.
nondrinkers for three high lipid indices were also signifi-
cantly lower than the reference level (Table 3), and these
very low odds ratios may reflect the very low odds ratios
for the high LDL-C/HDL-C ratio of heavy drinkers vs.
nondrinkers (Table 2).
Discussion
The results of the covariance analysis and logistic regres-
sion analysis indicated that there is a linear inverse rela-
tionship between alcohol intake and the LDL-C/HDL-C
ratio, a nonlinear inverse relationship between alcohol
intake and the TG/HDL-C ratio, and a J-shaped relation-
ship between alcohol intake and LAP. The findings of fa-
vorable associations between light-to-moderate drinking























e and heavy drinkers in patients with diabetes. The mean levels of
ransformed LAP) were calculated after adjustment for age, smoking,
d to covariates to calculate the means of the variables other than LAP.
ight drinkers (†, p < 0.05; ††, p < 0.01).
Table 2 The odds ratios for the high LDL-C/HDL-C ratio, high TG/HDL-C ratio and high LAP of the light, moderate and
heavy drinker groups vs. the nondrinker group in subjects with diabetes
Nondrinkers Light drinkers Moderate drinkers Heavy drinkers
High LDL-C/HDL-C ratio
Crude OR 1.00 0.68 (0.43-1.07) 0.22 (0.14-0.34)** 0.11 (0.05-0.21)**
Adjusted OR 1.00 0.80 (0.50-1.29) 0.24 (0.15-0.38)** 0.10 (0.05-0.19)**
High TG/HDL-C ratio
Crude OR 1.00 0.47 (0.32-0.69)** 0.65 (0.50-0.84)** 0.77 (0.58-1.03)##
Adjusted OR 1.00 0.54 (0.36-0.80)** 0.73 (0.56-0.97)* 0.72 (0.53-0.98)*
High LAP
Crude OR 1.00 0.51 (0.34-0.76)** 0.73 (0.56-0.96)* 1.23 (0.92-1.63)
Adjusted OR 1.00 0.66 (0.43-1.02)# 0.82 (0.61-1.10) 1.29 (0.95-1.77)
The crude and adjusted odds ratios (ORs) are shown with their 95% confidence intervals indicated in the parentheses. The adjusted odds ratios for the high LDL-C
/HDL-C ratio, high TG/HDL-C ratio, and high LAP of each drinker group vs. nondrinkers were calculated using age, smoking, regular exercise and drug therapy for
diabetes as other explanatory variables. Body weight was also used as an explanatory variable to calculate the adjusted odds ratios for high LDL-C/HDL-C ratio
and high TG/HDL-C ratio. Symbols denote significantly lower odds ratios compared with a reference level of 1.00 (*, p < 0.05; **, p < 0.01). Marginally significant
differences from the reference level (#, p = 0.060; ##, p = 0.077).
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cumulated risk of a high lipid index (Table 3). Therefore,
in patients with diabetes, light-to-moderate alcohol con-
sumption should lower these lipid-related indices, while
the relationships between heavy alcohol intake and lipid
indices differ by each lipid index. These associations
between alcohol intake and lipid indices were similar to
those found in a general population of Japanese subjects
in previous studies [21-23].
This is the first study in which the relationships of
alcohol intake with different lipid indices in patients
with diabetes were compared. Although the TG/HDL-C
ratio was higher in heavy drinkers than in light drinkers
in the present study, a recent study by a Belgian group
using 585 male patients with type 2 diabetes showed a
linear inverse relationship between alcohol intake and
the quintile of TG/HDL-C ratio in a univariate analysisTable 3 The odds ratios for the accumulation of high lipid-rel
ratio and high LAP) of the light, moderate and heavy drinker
diabetes
Nondrinkers Light drinker
≥ 1 high index
Crude OR 1.00 0.54 (0.38-0.77
Adjusted OR 1.00 0.63 (0.43-0.91
≥ 2 high indices
Crude OR 1.00 0.51 (0.34-0.76
Adjusted OR 1.00 0.63 (0.42-0.96
3 high indices
Crude OR 1.00 0.36 (0.17-0.76
Adjusted OR 1.00 0.51 (0.24-1.11
The crude and adjusted odds ratios (ORs) are shown with their 95% confidence inte
or 3 high indices from the high LDL-C/HDL-C ratio, high TG/HDL-C ratio and high L
smoking, regular exercise and drug therapy for diabetes were used as other explan
a reference level of 1.00 (*, p < 0.05; **, p < 0.01). A marginally significant difference[29]. A possible explanation for this discrepancy in the
relationship between the TG/HDL-C ratio and heavy
drinking is an ethnicity-dependent difference in the rela-
tionship between alcohol and blood lipids.
The lipid indices used in this study were determined
by two variables out of triglycerides, HDL cholesterol,
LDL cholesterol and waist circumference. A decrease in
the LDL-C/HDL-C ratio with an increase in alcohol
intake is reasonable, since HDL cholesterol and LDL
cholesterol increased and decreased, respectively, with
an increase in alcohol intake. While there was a positive
linear association between alcohol intake and HDL chol-
esterol, the triglyceride levels were slightly lower in light
drinkers and higher in heavy drinkers when compared
with those in nondrinkers. These relationships resulted in
a lower TG/HDL-C ratio in light and moderate drinkers
than in nondrinkers and a smaller difference in the TG/ated indices (high LDL-C/HDL-C ratio, high TG/HDL-C
groups vs. the nondrinker group of subjects with
s Moderate drinkers Heavy drinkers
)** 0.57 (0.44-0.73)** 0.82 (0.62-1.08)
)* 0.60 (0.46-0.79)** 0.79 (0.59-1.06)
)** 0.59 (0.45-0.78)** 0.80 (0.60-1.08)
)* 0.63 (0.47-0.85)** 0.76 (0.55-1.05)
)** 0.30 (0.18-0.52)** 0.12 (0.05-0.30)**
)# 0.35 (0.20-0.61)** 0.11 (0.04-0.27)**
rvals indicated in the parentheses. The odds ratios vs. nondrinkers for ≥ 1, ≥ 2
AP in each drinker group were calculated. In the multivariate analysis, age,
atory variables. Symbols denote significantly lower odds ratios compared with
from the reference level (#, p = 0.091).
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compared with the differences between nondrinkers and
light or moderate drinkers. LAP was significantly higher
in heavy drinkers than in light drinkers and showed a
J-shaped relationship with alcohol intake, although the
difference in LAP between each drinker group and the
nondrinker group was not statistically significant. The as-
sociation between alcohol intake and LAP was due to the
slightly smaller waist circumference and lower triglycer-
ides in light drinkers than in nondrinkers and was due to
higher triglycerides in heavy drinkers than in nondrinkers.
Although each lipid index examined in this study
showed diverse relationships with heavy drinking, light-
to-moderate alcohol intake was inversely associated with
all of the lipid indices in patients with diabetes. This
agrees with previous epidemiological findings that light-to
-moderate alcohol consumption reduced the risk of coron-
ary artery disease not only in a general population [1] but
also in patients with diabetes [30,31]. However, needless to
say, drinking alcohol even if lightly or moderately should
not be recommended to patients with diabetes for the pre-
vention of cardiovascular complications, since drinking
could disturb diet therapy and induce hypoglycemia in pa-
tients receiving treatment with anti-diabetic drugs.
There are some limitations of this study. Diabetes was
diagnosed by the level of hemoglobin A1c in the health
check-up examination and a history of drug therapy for
diabetes, as assessed in the questionnaire. Thus, there is
a possibility of an informational bias regarding the diag-
nosis of diabetes. In addition, the type of diabetes was
not identified for each subject of this study. However,
the type for most of the subjects is expected to be type 2
diabetes because the prevalence of type 2 diabetes is
speculated to be > 100-times higher than that of type 1
diabetes in middle-aged Japanese men according to
statistics [32]. Although age, body weight, smoking and
exercise were adjusted in the multivariate analyses, the
relationships between alcohol intake and lipid indices
may have possibly been confounded by other factors
such as diet, nutrition and socioeconomic factors, which
were not included in the database used in this study. In
addition, there is a possibility of confounding by poly-
morphisms in alcohol-metabolizing enzymes such as
ADH (alcohol dehydrogenase) and ALDH (aldehyde de-
hydrogenase). Polymorphisms of genes related to lipid
metabolism have also been reported to interact with
overweight/obesity to influence blood lipid levels [33].
Moreover, apolipoprotein E gene polymorphisms have
been shown to be associated with the lipid profile and
prevalence of type 2 diabetes [34]. Therefore, polymor-
phisms of not only alcohol-metabolizing enzyme genes,
but also lipid-related genes, are possible confounders for
the relationships between the alcohol intake and lipid
indices in patients with diabetes. The subjects of thisstudy were middle-aged Japanese men, and there is a pos-
sibility that the relationships between alcohol and the lipid
indices are modified by age, gender and ethnicity. In fact,
the TG/HDL-C ratio has been reported not to show a sig-
nificant relation to insulin resistance in African-American
women [35]. Finally, this study was cross-sectional in its
design, and further prospective studies are needed to elu-
cidate causality of the association between alcohol con-
sumption and the lipid indices.
Conclusion
In conclusion, in patients with diabetes, there were signifi-
cant inverse associations between light-to-moderate alco-
hol consumption and lipid-related indices. This supports
the hypothesis that mild alcohol consumption reduces the
risk of cardiovascular disease through improving the lipid
profile in patients with diabetes.
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